Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsR&D In Process
Ratios

Zenas BioPharma (ZBIO) Leases (2023 - 2025)

Zenas BioPharma has reported Leases over the past 3 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Leases at $1.4 million for Q4 2025, up 34.86% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (up 34.86% YoY), and the annual figure for FY2025 was $1.4 million, up 34.86%.
  • Leases for Q4 2025 was $1.4 million at Zenas BioPharma, up from $807000.0 in the prior quarter.
  • Over the last five years, Leases for ZBIO hit a ceiling of $1.4 million in Q4 2025 and a floor of $399000.0 in Q3 2024.
  • Median Leases over the past 3 years was $1.0 million (2024), compared with a mean of $942714.3.
  • Biggest five-year swings in Leases: increased 22.29% in 2024 and later soared 102.26% in 2025.
  • Zenas BioPharma's Leases stood at $821000.0 in 2023, then increased by 22.29% to $1.0 million in 2024, then skyrocketed by 34.86% to $1.4 million in 2025.
  • The last three reported values for Leases were $1.4 million (Q4 2025), $807000.0 (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.